Genetic risk and long-term outcomes associated with drug-induced stevens-johnson syndrome and toxic epidermal necrolysis in survivors

Ended Project Grant Awarded Last action

Award ID
R01HG010863
Recipient
Awarding agency
Obligated
$5,546,745

Award facts

Assistance listing
93.172 Human Genome Research
Completion date
Originally
Funding
  • $4,730,475.21 Federal
  • $816,270.00 Non-federal
Place of performance
Nashville, TN 37203, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$4 $0
Amendment $0 $0
Amendment $799,660 $0
Amendment $799,660 $0
Amendment $816,270 $0
Amendment $816,270 $816,270
Amendment $755,862 $0
Original award $742,757 $0

Subawards

Subrecipient Amount Awarded
Women's College Hospital Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors $5,000

Quick answers

Who received award R01HG010863?

R01HG010863 was awarded to Vanderbilt University Medical Center by National Human Genome Research Institute (National Institutes of Health) on September 13, 2019.

How much is award R01HG010863 worth?

$5,546,745 has been obligated on R01HG010863: $4,730,475 in federal funding and $816,270 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award